DeciBio Consulting
DeciBio Consulting is a specialist strategy and market intelligence firm focused on precision medicine, diagnostics, research tools, life sciences, and healthcare technology.
- Highest 2026 tier: Tier II
- Corporate strategy advisory firm
- 2 Advisory Ranking categories
Overview
DeciBio Consulting is a specialist strategy and market intelligence firm focused on precision medicine, diagnostics, research tools, life sciences, and healthcare technology. The firm provides commercial due diligence, market assessment, technology evaluation, voice-of-customer research, competitive analysis, and growth strategy support.
The firm’s work can support market entry, product strategy, competitive positioning, technology assessment, partnership strategy, commercialization planning, and investment decision-making. Its specialist orientation gives it a sharper profile than generalist healthcare consultancies in certain technical niches.
DeciBio Consulting is included in 2 2026 Advisory Ranking categories. The highest recorded classification is Tier II.
Firm facts
| Founded | 2009 |
| Firm type | Corporate strategy advisory firm |
| Headquarters | Los Angeles, United States |
| Primary focus | Growth strategy, portfolio choices and strategic transformation |
| Highest 2026 Advisory Ranking tier | Tier II |
Principal activities
Market assessment
Market size, growth, segmentation, regulation and structural attractiveness.
Corporate and growth strategy
Enterprise strategy, growth priorities and market positioning.
Customer and competitor analysis
Voice-of-customer research, competitive positioning and commercial benchmarking.
DeciBio Consulting works with clients on assignments that may combine strategy, specialist analysis, implementation support and organizational adoption. The precise scope depends on the mandate, sector, geography and client requirements.
Sector and mandate coverage
Sector coverage
- Private equity
- Technology
- Healthcare
- Consumer markets
- Industrials
- Financial services
Mandate types
- Buy-side CDD
- Corporate strategy
- Vendor CDD
- Growth strategy
- Market sizing
- Portfolio strategy
Market position
DeciBio Consulting is positioned as a corporate strategy advisory firm. Its relevance reflects the combination of specialist capability, institutional experience and practical involvement in consequential strategic or corporate decisions.
Distinctive focus: Its CDD work is especially relevant for investors evaluating complex healthcare assets where scientific novelty, regulatory pathways, reimbursement conditions, customer adoption, and technology differentiation all influence market potential.
Competitive context
DeciBio Consulting competes with specialist strategy advisers, executive-services firms, transaction advisers, analytics providers and larger multidisciplinary professional-services firms. The relevant peer set varies by mandate, industry, client segment, geographic scope and delivery model.
Comparable firms are selected according to overlap in business model, client segment, service coverage, geographic activity and mandate profile. Inclusion does not imply equivalence in scale, ranking or market position.
Leadership
| Person | Current position | Institutional background |
|---|
Leadership information reflects the public sources reviewed for this profile. View the firm’s website ↗
Corporate and regulatory information
DeciBio Consulting provides advisory, executive, analytical, transaction, managed or technology services. The contracting entity, professional obligations and regulatory status depend on the service, client jurisdiction and engagement scope.
View registered-entity details
| Service status | Advisory, executive, analytical, transaction or technology services |
| Headquarters | Los Angeles, United States |
Principal offices
- Los Angeles, United States
Rankings and recognition
Ranking inclusion is editorially determined. The existence or maintenance of a Wiki profile does not influence ranking eligibility, tier or position.
Related Economy analysis
Selected Economy Markets articles providing context for the firm’s advisory environment:
- The Silent Reshuffle of the Advisory Market
- How AI Is Reshaping the Consulting Industry in 2026
- Middle-Market Private Equity: Returns, Scale and Manager Selection
Related institutions and subjects
Sources and data transparency
The profile is based on the following publicly available institutional, regulatory and editorial sources:
- DeciBio Consulting — official firm overview and service information.
- Advisory Ranking — Top 30 Commercial Due Diligence (CDD) Advisory 2026 — inclusion and tier classification.
- Advisory Ranking — Top 30 Corporate Strategy Advisory 2026 — inclusion and tier classification.
